Status:
COMPLETED
Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)
Lead Sponsor:
Seoul National University Hospital
Conditions:
Intubation
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Midazolam has been used in rapid sequence intubation for a long time, and the recommended dose is 0.1mg/kg. In some studies, however, the reduced dose has been used with the concern of hemodynamic ins...
Eligibility Criteria
Inclusion
- patients who need rapid sequence intubation in emergency room
Exclusion
- in hypotension(systolic blood pressure less than 90 mmHg
- severe trauma patients
- pregnant
- allergic to midazolam, etomidate
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
End Date :
January 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00783731
Start Date
October 1 2008
End Date
January 1 2011
Last Update
July 26 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital, Emergency room
Seongnam-si, Gyeonggi-do, South Korea, 463-707
2
Boramae Medical Center
Seoul, South Korea, 156-707